FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022676940> ?p ?o ?g. }

• W2022676940 endingPage "501" @default.
• W2022676940 startingPage "488" @default.
• W2022676940 abstract "The occurrence of chronic stress, depression, and anxiety can increase nociception in humans and may facilitate the transition from localized to chronic widespread pain. The mechanisms underlying chronic widespread pain are still unknown, hindering the development of effective pharmacological therapies. Here, we exposed C57BL/6J mice to chronic unpredictable stress (CUS) to investigate how persistent stress affects nociception. Next, mice were treated with multiple intramuscular nerve growth factor (NGF) injections, which induced chronic widespread nociception. Thus, combination of CUS and NGF served as a model where psychophysiological impairment coexists with long-lasting hyperalgesia. We found that CUS increased anxiety- and depression-like behavior and enhanced basal nociception in mice. When co-applied with repeated NGF injections, CUS elicited a sustained long-lasting widespread hyperalgesia. In order to evaluate a potential therapeutic strategy for the treatment of chronic pain associated with stress, we hypothesized that the endocannabinoid system (ECS) may represent a target signaling system. We found that URB597, an inhibitor of the anandamide-degrading enzyme fatty acid amide hydrolase (FAAH), and JZL184, an inhibitor of the 2-arachidonoyl glycerol-degrading enzyme monoacylglycerol lipase (MAGL), increased eCB levels in the brain and periphery and were both effective in reducing CUS-induced anxiety measured by the light–dark test and CUS-induced thermal hyperalgesia. Remarkably, the long-lasting widespread hyperalgesia induced by combining CUS and NGF was effectively reduced by URB597, but not by JZL184. Simultaneous inhibition of FAAH and MAGL did not improve the overall therapeutic response. Therefore, our findings indicate that enhancement of anandamide signaling with URB597 is a promising pharmacological approach for the alleviation of chronic widespread nociception in stress-exposed mice, and thus, it could represent a potential treatment strategy for chronic pain associated with neuropsychiatric disorders in humans." @default.
• W2022676940 created "2016-06-24" @default.
• W2022676940 creator A5001976717 @default.
• W2022676940 creator A5023263973 @default.
• W2022676940 creator A5032433323 @default.
• W2022676940 creator A5054823577 @default.
• W2022676940 creator A5058483451 @default.
• W2022676940 creator A5069629033 @default.
• W2022676940 creator A5074499708 @default.
• W2022676940 date "2014-08-06" @default.
• W2022676940 modified "2023-10-14" @default.
• W2022676940 title "Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain" @default.
• W2022676940 cites W1574836546 @default.
• W2022676940 cites W1969415886 @default.
• W2022676940 cites W1970679074 @default.
• W2022676940 cites W1972861207 @default.
• W2022676940 cites W1986674596 @default.
• W2022676940 cites W1991349787 @default.
• W2022676940 cites W2001236360 @default.
• W2022676940 cites W2002172757 @default.
• W2022676940 cites W2004071649 @default.
• W2022676940 cites W2005449195 @default.
• W2022676940 cites W2008565294 @default.
• W2022676940 cites W2009740794 @default.
• W2022676940 cites W2013744734 @default.
• W2022676940 cites W2015426635 @default.
• W2022676940 cites W2016354440 @default.
• W2022676940 cites W2017255572 @default.
• W2022676940 cites W2018723047 @default.
• W2022676940 cites W2023228665 @default.
• W2022676940 cites W2023392979 @default.
• W2022676940 cites W2029471635 @default.
• W2022676940 cites W2032353684 @default.
• W2022676940 cites W2032472307 @default.
• W2022676940 cites W2032977192 @default.
• W2022676940 cites W2033835916 @default.
• W2022676940 cites W2037393750 @default.
• W2022676940 cites W2042831008 @default.
• W2022676940 cites W2051077021 @default.
• W2022676940 cites W2051554315 @default.
• W2022676940 cites W2054176374 @default.
• W2022676940 cites W2061313081 @default.
• W2022676940 cites W2062462607 @default.
• W2022676940 cites W2063210405 @default.
• W2022676940 cites W2067214410 @default.
• W2022676940 cites W2071848914 @default.
• W2022676940 cites W2081999534 @default.
• W2022676940 cites W2083910964 @default.
• W2022676940 cites W2084283702 @default.
• W2022676940 cites W2085064258 @default.
• W2022676940 cites W2085089223 @default.
• W2022676940 cites W2090774121 @default.
• W2022676940 cites W2090822307 @default.
• W2022676940 cites W2090836509 @default.
• W2022676940 cites W2123228137 @default.
• W2022676940 cites W2124037107 @default.
• W2022676940 cites W2125609354 @default.
• W2022676940 cites W2132380973 @default.
• W2022676940 cites W2153438496 @default.
• W2022676940 cites W2155801131 @default.
• W2022676940 cites W2162944217 @default.
• W2022676940 cites W2163953252 @default.
• W2022676940 cites W2165780882 @default.
• W2022676940 cites W2171519074 @default.
• W2022676940 cites W2172201406 @default.
• W2022676940 cites W4241363254 @default.
• W2022676940 doi "https://doi.org/10.1038/npp.2014.198" @default.
• W2022676940 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4443964" @default.
• W2022676940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25100669" @default.
• W2022676940 hasPublicationYear "2014" @default.
• W2022676940 type Work @default.
• W2022676940 sameAs 2022676940 @default.
• W2022676940 citedByCount "110" @default.
• W2022676940 countsByYear W20226769402015 @default.
• W2022676940 countsByYear W20226769402016 @default.
• W2022676940 countsByYear W20226769402017 @default.
• W2022676940 countsByYear W20226769402018 @default.
• W2022676940 countsByYear W20226769402019 @default.
• W2022676940 countsByYear W20226769402020 @default.
• W2022676940 countsByYear W20226769402021 @default.
• W2022676940 countsByYear W20226769402022 @default.
• W2022676940 countsByYear W20226769402023 @default.
• W2022676940 crossrefType "journal-article" @default.
• W2022676940 hasAuthorship W2022676940A5001976717 @default.
• W2022676940 hasAuthorship W2022676940A5023263973 @default.
• W2022676940 hasAuthorship W2022676940A5032433323 @default.
• W2022676940 hasAuthorship W2022676940A5054823577 @default.
• W2022676940 hasAuthorship W2022676940A5058483451 @default.
• W2022676940 hasAuthorship W2022676940A5069629033 @default.
• W2022676940 hasAuthorship W2022676940A5074499708 @default.
• W2022676940 hasBestOaLocation W20226769401 @default.
• W2022676940 hasConcept C126322002 @default.
• W2022676940 hasConcept C148001335 @default.
• W2022676940 hasConcept C15490471 @default.
• W2022676940 hasConcept C15744967 @default.
• W2022676940 hasConcept C169760540 @default.
• W2022676940 hasConcept C170493617 @default.
• W2022676940 hasConcept C2778938600 @default.

• next